Blood Pressure-Attained Analysis of ATACH 2 Trial
- 1 June 2018
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 49 (6), 1412-1418
- https://doi.org/10.1161/strokeaha.117.019845
Abstract
Background and Purpose— We compared the rates of death or disability, defined by modified Rankin Scale score of 4 to 6, at 3 months in patients with intracerebral hemorrhage according to post-treatment systolic blood pressure (SBP)–attained status. Methods— We divided 1000 subjects with SBP ≥180 mm Hg who were randomized within 4.5 hours of symptom onset as follows: SBP <140 mm Hg achieved or not achieved within 2 hours; subjects in whom SBP <140 mm Hg was achieved within 2 hours were further divided: SBP <140 mm Hg for 21 to 22 hours (reduced and maintained) or SBP was ≥140 mm Hg for at least 2 hours during the period between 2 and 24 hours (reduced but not maintained). Results— Compared with subjects without reduction of SBP <140 mm Hg within 2 hours, subjects with reduction and maintenance of SBP <140 mm Hg within 2 hours had a similar rate of death or disability (relative risk of 0.98; 95% confidence interval, 0.74–1.29). The rates of neurological deterioration within 24 hours were significantly higher in reduced and maintained group (10.4%; relative risk, 1.98; 95% confidence interval, 1.08–3.62) and in reduced but not maintained group (11.5%; relative risk, 2.08; 95% confidence interval, 1.15–3.75) compared with reference group. The rates of cardiac-related adverse events within 7 days were higher among subjects with reduction and maintenance of SBP <140 mmHg compared to subjects without reduction (11.2% versus 6.4%). Conclusions— No decline in death or disability but higher rates of neurological deterioration and cardiac-related adverse events were observed among intracerebral hemorrhage subjects with reduction with and without maintenance of intensive SBP goals. Clinical Trial Registration— URL: https://www.clinicaltrials.gov. Unique identifier: NCT01176565.Keywords
This publication has 26 references indexed in Scilit:
- The Importance of Acute Hypertensive Response in ICHStroke, 2013
- Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: Design, Methods, and RationaleNeurocritical Care, 2011
- Contribution of arterial Windkessel in low-frequency cerebral hemodynamics during transient changes in blood pressureJournal of Applied Physiology, 2011
- Intracerebral Hemorrhage Specific Intensity of Care Quality MetricsNeurocritical Care, 2010
- Lower Treatment Blood Pressure Is Associated With Greatest Reduction in Hematoma Growth After Acute Intracerebral HemorrhageHypertension, 2010
- Secondary decline of cerebral autoregulation is associated with worse outcome after intracerebral hemorrhageIntensive Care Medicine, 2009
- Dynamic pressure–flow relationship of the cerebral circulation during acute increase in arterial pressureThe Journal of Physiology, 2009
- The ECLIPSE Trials: Comparative Studies of Clevidipine to Nitroglycerin, Sodium Nitroprusside, and Nicardipine for Acute Hypertension Treatment in Cardiac Surgery PatientsAnesthesia & Analgesia, 2008
- PROSPECTIVE RANDOMIZED COMPARISON OF SAFETY AND EFFICACY OF NICARDIPINE AND NITROPRUSSIDE DRIP FOR CONTROL OF HYPERTENSION IN THE NEUROSURGICAL INTENSIVE CARE UNITNeurosurgery, 2008
- Changes in Cost and Outcome Among US Patients With Stroke Hospitalized in 1990 to 1991 and Those Hospitalized in 2000 to 2001Stroke, 2007